| Carbazole scaffolds in cancer therapy: a review from 2012 to 2018 S Issa, A Prandina, N Bedel, P Rongved, S Yous, M Le Borgne, Z Bouaziz Journal of enzyme inhibition and medicinal chemistry 34 (1), 1321-1346, 2019 | 126 | 2019 |
| Synthesis and biological evaluation of novel substituted pyrrolo [1, 2-a] quinoxaline derivatives as inhibitors of the human protein kinase CK2 J Guillon, M Le Borgne, C Rimbault, S Moreau, S Savrimoutou, N Pinaud, ... European Journal of Medicinal Chemistry 65, 205-222, 2013 | 106 | 2013 |
| Indeno [1, 2-b] indole derivatives as a novel class of potent human protein kinase CK2 inhibitors C Hundsdörfer, HJ Hemmerling, C Götz, F Totzke, P Bednarski, ... Bioorganic & medicinal chemistry 20 (7), 2282-2289, 2012 | 95 | 2012 |
| Synthesis and antifungal activities of new fluconazole analogues with azaheterocycle moiety N Lebouvier, F Pagniez, M Duflos, P Le Pape, YM Na, G Le Baut, ... Bioorganic & medicinal chemistry letters 17 (13), 3686-3689, 2007 | 95 | 2007 |
| New selective nonsteroidal aromatase inhibitors: synthesis and inhibitory activity of 2, 3 or 5-(α-azolylbenzyl)-1H-indoles M Le Borgne, P Marchand, B Delevoye-Seiller, JM Robert, G Le Baut, ... Bioorganic & medicinal chemistry letters 9 (3), 333-336, 1999 | 84 | 1999 |
| Fragment linking strategies for structure-based drug design A Bancet, C Raingeval, T Lomberget, M Le Borgne, JF Guichou, I Krimm Journal of Medicinal Chemistry 63 (20), 11420-11435, 2020 | 81 | 2020 |
| Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl) methyl]-1H-indoles: potent and selective aromatase inhibitors MP Lézé, M Le Borgne, P Pinson, A Palusczak, M Duflos, G Le Baut, ... Bioorganic & medicinal chemistry letters 16 (5), 1134-1137, 2006 | 81 | 2006 |
| 2-and 3-[(aryl)(azolyl) methyl] indoles as potential non-steroidal aromatase inhibitors MP Lézé, ML Borgne, P Marchand, D Loquet, M Kogler, GL Baut, ... Journal of Enzyme Inhibition and Medicinal Chemistry 19 (6), 549-557, 2004 | 74 | 2004 |
| Cobalt–Chromium dental alloys: Metal exposures, toxicological risks, CMR classification, and EU regulatory framework A Vaicelyte, C Janssen, M Le Borgne, B Grosgogeat Crystals 10 (12), 1151, 2020 | 72 | 2020 |
| Converting Potent Indeno[1,2-b]indole Inhibitors of Protein Kinase CK2 into Selective Inhibitors of the Breast Cancer Resistance Protein ABCG2 G Jabor Gozzi, Z Bouaziz, E Winter, N Daflon-Yunes, D Aichele, ... Journal of Medicinal Chemistry 58 (1), 265-277, 2015 | 71 | 2015 |
| Potential application of plant lipid transfer proteins for drug delivery C Pato, M Le Borgne, G Le Baut, P Le Pape, D Marion, JP Douliez Biochemical pharmacology 62 (5), 555-560, 2001 | 71 | 2001 |
| Occurrence of the synthetic analgesic tramadol in an African medicinal plant. A Boumendjel, G Sotoing Taïwe, E Ngo Bum, T Chabrol, C Beney, ... Angewandte Chemie International Edition 52 (45), 2013 | 68 | 2013 |
| Synthesis and In Vitro Evaluation of 3‐(1‐Azolylmethyl)‐1H‐indoles and 3‐(1‐Azolyl‐1‐phenylmethyl)‐1H‐indoles as Inhibitors of P450 arom ML Borgne, P Marchand, M Duflos, B Delevoye‐Seiller, ... Archiv der Pharmazie 330 (5), 141-145, 1997 | 67 | 1997 |
| Synthesis and antifungal activity of new 1-halogenobenzyl-3-imidazolylmethylindole derivatives YM Na, M Le Borgne, F Pagniez, G Le Baut, P Le Pape European journal of medicinal chemistry 38 (1), 75-87, 2003 | 66 | 2003 |
| Synthesis and structure–activity relationships of 2-phenyl-1-[(pyridinyl-and piperidinylmethyl) amino]-3-(1H-1, 2, 4-triazol-1-yl) propan-2-ols as antifungal agents F Giraud, R Guillon, C Logé, F Pagniez, C Picot, M Le Borgne, P Le Pape Bioorganic & Medicinal Chemistry Letters 19 (2), 301-304, 2009 | 57 | 2009 |
| Synthesis of 6-or 4-functionalized indoles via a reductive cyclization approach and evaluation as aromatase inhibitors MP Lézé, A Palusczak, RW Hartmann, M Le Borgne Bioorganic & medicinal chemistry letters 18 (16), 4713-4715, 2008 | 49 | 2008 |
| Efficient microwave-assisted synthesis of 1-(1H-indol-1-yl)-2-phenyl-3-(1H-1, 2, 4-triazol-1-yl) propan-2-ols as antifungal agents N Lebouvier, F Giraud, T Corbin, YM Na, G Le Baut, P Marchand, ... Tetrahedron letters 47 (36), 6479-6483, 2006 | 49 | 2006 |
| Preparation and pharmacological profile of 7-(α-azolylbenzyl)-1H-indoles and indolines as new aromatase inhibitors P Marchand, M Le Borgne, M Palzer, G Le Baut, RW Hartmann Bioorganic & medicinal chemistry letters 13 (9), 1553-1555, 2003 | 49 | 2003 |
| Biological exploration of a novel 1, 2, 4-triazole-indole hybrid molecule as antifungal agent F Pagniez, N Lebouvier, YM Na, I Ourliac-Garnier, C Picot, M Le Borgne, ... Journal of enzyme inhibition and medicinal chemistry 35 (1), 398-403, 2020 | 47 | 2020 |
| Indenoindoles and cyclopentacarbazoles as bioactive compounds: synthesis and biological applications P Rongved, G Kirsch, Z Bouaziz, J Jose, M Le Borgne European Journal of Medicinal Chemistry 69, 465-479, 2013 | 47 | 2013 |
Joachim JoseUniversity of Münster, Institute of Pharmaceutical and Medicinal Chemsitry在 uni-muenster.de 的电子邮件经过验证
